Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00259155
Status:
COMPLETED
Last Update Posted:
2008-03-18
First Post:
2005-11-25
Brief Title:
Rifaximin for the Treatment of Irritable Bowel Syndrome
Sponsor:
Organization:
Cedars-Sinai Medical Center